11 | 0 | 6 |
下载次数 | 被引频次 | 阅读次数 |
目的 探究产复欣联合葆宫止血颗粒对前置胎盘剖宫产术后血性恶露持续时间及子宫复旧的影响。方法 选取2022年1月至2023年12月收治的行前置胎盘剖宫产术的产妇80例,采用随机信封法分为对照组和观察组各40例。对照组采用葆宫止血颗粒和缩宫素治疗,观察组在对照组基础上加用产复欣颗粒治疗。两组均治疗7 d后并随访42 d。比较两组患者子宫恢复情况(产后出血量、血性恶露持续时间以及恶露结束时间)、宫底恢复高度、子宫三径之和、子宫复旧效果以及不良反应发生情况。结果 观察组产后出血量少于对照组,血性恶露持续时间以及恶露结束时间均短于对照组(P<0.01);观察组产后3 d、5 d宫底下降幅度均大于对照组(P<0.01);观察组产后42 d子宫三径之和均小于对照组(P<0.05);观察组患者子宫复旧效果[97.50%(39/40)]优于对照组[82.50%(33/40)],差异有统计学意义(P<0.05);两组产妇不良反应发生率[12.50%(5/40)] vs [7.50%(3/40)]比较差异无统计学意义(P>0.05)。结论 产复欣联合葆宫止血颗粒能够改善前置胎盘剖宫产术后产妇的产后出血情况,缩短血性恶露持续时间,促进子宫收缩,加速子宫复旧进程,且具备安全性。
Abstract:Objective To investigate the effect of Chanfuxin combined with Baogong Zhixue granules on the duration of bloody lochia and uterine involution after cesarean section for placenta previa. Methods A total of 80 pregnant women with placenta previa who underwent cesarean section in our hospital from January 2022 to December 2023 were selected and divided into the control group(n=40) and the observation group(n=40) by random envelope method. The control group was treated with Baogong Zhixue granules and oxytocin, and the observation group was treated with Chanfuxin granules on the basis of the control group. Both groups were treated for 7 d and followed up for 42 d. The uterine recovery(postpartum hemorrhage, duration of bloody lochia and end time of lochia), height of fundus recovery, the sum of three uterine diameters,effect of uterine involution and adverse reactions were compared between the two groups. Results The amount of postpartum hemorrhage in the observation group was less than that in the control group, and the duration of bloodylochia and the end time of bloody lochia in the observation group were shorter than those in the control group(P<0.01). The decrease in the height of fundus recovery in the observation group was greater than that in the control group at 3 d and 5 d after delivery(P<0.01).The sum of the three uterine diameters in the observation group was lower than that in the control group at 42 d after delivery(P<0.05). The effect of uterine involution in the observation group was better than that in the control group [97.50%(39/40)vs. 82.50%(33/40)](P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups [12.50%(5/40) vs. 7.50%(3/40)](P>0.05). Conclusion Chanfuxin combined with Baogong Zhixue granules can alleviate postpartum hemorrhage in patients with placenta previa after cesarean section, shorten the duration of bloody lochia, promote uterine contraction, and accelerate the process of uterine involution, showing good safety.
[1]罗钰,杨堃,陈华梅,等.氨甲环酸应用于凶险型前置胎盘剖宫产术中的有效性及安全性[J].西部医学,2020,32(11):1612-1615.
[2]赵琳琳,高伟佳,李磊.氨甲环酸联合卡贝缩宫素预防前置胎盘产后出血及对应激反应和卵巢储备功能的影响[J].中国药物应用与监测,2024,21(4):427-432.
[3]武柳君,代良萍,谢晓芳,等.益母草注射液水溶性总生物碱对产后子宫复旧中子宫收缩活动的影响[J].世界科学技术-中医药现代化,2023,25(8):2775-2784.
[4]唐波,刘晓芳,何玉春,等.低强度超声促进剖宫产术后子宫复旧的随机对照临床研究[J].重庆医学,2019,48(16):2775-2778.
[5]陈佳,常淑芳,孙江川,等.卡前列素氨丁三醇预防性应用在中央性前置胎盘剖宫产术中的效果[J].检验医学与临床,2019,16(4):453-455.
[6]刘铭,吴坤英,徐巍,等.产复欣颗粒对人工流产术后出血量与促进子宫复旧的临床观察[J].新中医,2021,53(13):90-92.
[7]张红,郑淑敏,孙春亭,等.葆宫止血颗粒辅助促进产后子宫复旧的临床效果分析[J].世界中医药,2021,16(17):2626-2630.
[8] JAIN V, BOS H, BUJOLD E. Guideline No. 402:diagnosis and management of placenta previa[J].J Obstet Gynaecol Can,2020,42(7):906-917.
[9]中华医学会妇产科学分会产科学组.剖宫产手术的专家共识(2014)[J].中华妇产科杂志,2014,49(10):721-724.
[10]措毛吉,才德吉,万玛南杰,等.独参汤结合米索前列醇对产后宫缩乏力性出血凝血功能和子宫复旧状况的影响[J].中华中医药学刊,2024,42(7):214-217.
[11]朱虹星,沈明霞.益气和血通脉方治疗剖宫产后恶露不绝的疗效观察[J].中国中医药科技,2023,30(2):384-386.
[12]王春延.中药汤剂联合西药治疗气虚血瘀型产后恶露不绝临床研究[J].新中医,2022,54(19):152-155.
[13]刘孚嘉,卢红蓉,赵晨希.吴鞠通《温病条辨》血瘀病机与用药特点[J].中国中医基础医学杂志,2024,30(7):1141-1143.
[14]裘琼琪.生化汤加味联合扶阳罐治疗产后血瘀型恶露不绝的疗效观察[J].中国中医药科技,2023,30(3):569-570.
[15]楼国平,金媛芝,楼登云.葆宫止血颗粒治疗药物流产后子宫出血临床研究[J].新中医,2020,52(4):80-82.
[16]郑春燕,曾诚,梁佳琪,等,陈思达.产复康颗粒促进人工流产术后恢复疗效观察[J].现代中西医结合杂志,2019,28(23):2548-2552.
[17]周彤,米建锋.产复康颗粒联合卡前列甲酯栓治疗产后出血的效果观察[J].中国医药,2023,18(8):1244-1247.
[18]谢果珍,芮毅.生化汤与产复康颗粒治疗产后恶露不绝及促子宫复旧临床对照研究[J].中医临床研究,2022,14(6):74-76.
[19]潘忠敏,陶佳,徐峰.麦角新碱联合欣母沛预防高危产妇产后出血临床效果及对子宫复旧的影响[J].临床与病理杂志,2021,41(11):2626-2631.
[20]李小艳.欣母沛联合马来酸麦角新碱预防阴道分娩产后出血的有效性及产后恢复的影响[J].河北医学,2020,26(6):1029-1032.
[21]廖丹,李桂花,黄广翅.葆宫止血颗粒联合醋酸甲羟孕酮治疗围绝经期异常子宫出血(阴虚血热证)的效果观察[J].中国药房,2024,35(17):2131-2135.
[22]贺文建,吴桐,刘翠.葆宫止血颗粒联合安列克预防剖宫产患者产后出血效果研究[J].湖北中医药大学学报,2024,26(6):70-72.
[23]张淑娟.葆宫止血颗粒结合标准化治疗排卵障碍性异常子宫出血的疗效[J].中国标准化,2024(18):293-296.
[24]佘静,杨雅莉,王辉,等.葆宫止血颗粒用于产后出血的临床观察[J].中华中医药学刊,2019,37(10):2507-2510.
[25]吕晓芳,翟小娅,谢津,等.当归芍药散预防直径<6 cm妊娠期子宫肌瘤剖宫产术后出血的效果及对子宫血流动力学的影响[J].临床误诊误治,2021,34(9):40-44.
[26]徐婕,于虹敏,陈丽琴,等.基于数据挖掘和网络药理学研究含益母草处方“异病同治”月经类病、产后类病和胎孕类病的机制[J].中医药通报,2023,22(2):31-35.
[27]李淑平,刘秀华,刘丹丹,等.剖宫产术后应用阿胶生化汤促进子宫复旧的临床研究[J].菏泽医学专科学校学报,2023,35(3):49-52.
[28]孟永丽,李晖.菟丝子活性成分预防复发性流产作用机制研究进展[J].江苏中医药,2023,55(1):73-77.
[29]根玉,乌日汉,萨出日拉,等.P-gp/NF-kB协同作用的枸杞子-7防治子宫内膜异位症复发的作用机制分析[J].辽宁中医杂志,2022,49(10):205-208,后插5-后插6.
[30]王路路,胡巍,黎浩,等.地骨皮甲醇部位的化学成分及其抗炎活性研究[J].中成药,2024,46(5):1540-1545.
[31]韦宇,张琪棋,张湘苑,等.重构本草:蒲黄[J].吉林中医药,2025,45(1):99-103.
[32]江延姣,骆红飞,王荣俊,等.重楼生化汤中药配方颗粒预防剖宫产术后恶露不净效果观察[J].中国药师,2021,24(6):1091-1094.
[33]李亚荣,何卫宁.葆宫止血颗粒治疗药物流产后持续阴道出血的效果[J].实用临床医药杂志,2020,24(20):97-99.
[34]高香丽,沈金凤,刘妍.葆宫止血颗粒联合益母草分散片促进产后子宫复旧的临床疗效观察[J].中国性科学,2019,28(11):126-130.
[35]刘荣,闫凤乐.葆宫止血颗粒联合西药治疗药物流产后子宫异常出血临床研究[J].新中医,2021,53(19):134-137.
基本信息:
DOI:
中图分类号:R719.8
引用信息:
[1]刘翠,张红霞,于鹏等.产复欣联合葆宫止血颗粒对前置胎盘剖宫产术后血性恶露持续时间及子宫复旧的影响[J].临床误诊误治,2025,38(12):104-107+112.
基金信息:
山东省医学会科研专项资金项目(YXH2022ZX06298)